Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function

Introduction: Allogeneic stem cell transplantation (ASCT) is a crucial therapeutic strategy for hematological and non-hematological disorders. Poor graft function (PGF) after ASCT presents a critical challenge that does not have a standardized treatment approach. A thrombopoietin-mimetic oral drug e...

Descripción completa

Detalles Bibliográficos
Autores principales: Arslan Davulcu, Eren, Akad Soyer, Nur, Vural, Filiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544786/
https://www.ncbi.nlm.nih.gov/pubmed/37790070
http://dx.doi.org/10.7759/cureus.44555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544786/
https://www.ncbi.nlm.nih.gov/pubmed/37790070
http://dx.doi.org/10.7759/cureus.44555

Ejemplares similares